BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tovey FI, Husband EM, Yiu YC, Baker L, McPhail G, Lewin MR, Jayaraj AP, Clark CG. Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study. Gut 1989;30:586-93. [PMID: 2731750 DOI: 10.1136/gut.30.5.586] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Pugh S, Jayaraj A, Bardhan K. Duodenal mucosal histology and histochemistry in active, treated and healed duodenal ulcer: Correlation with duodenal prostaglandin E 2 production. J Gastroenterol Hepatol 1996;11:120-4. [DOI: 10.1111/j.1440-1746.1996.tb00047.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
2 Hochain P, Merle V, Tuil S, Michel P, Ducrotte P, Lerebours E, Colin R, Dao T. Transfusion for variceal bleeding in cirrhotic patients. Gut 1996;38:154. [PMID: 8566849 DOI: 10.1136/gut.38.1.154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Asaka M, Takeda H, Saito M, Murashima Y, Miyazaki T. Clinical efficacy of sucralfate in the treatment of gastric ulcer. The American Journal of Medicine 1991;91:S71-83. [DOI: 10.1016/0002-9343(91)90455-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
4 Lam SK, Ching CK. Sucralfate in clinical practice. J Gastroenterol Hepatol 1994;9:401-11. [DOI: 10.1111/j.1440-1746.1994.tb01263.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
5 Harris AW, Gummett PA, Walker MM, Misiewicz JJ, Baron JH. Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb. Gut. 1996;39:513-520. [PMID: 8944558 DOI: 10.1136/gut.39.4.513] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
6 Tovey FI, Yiu YC, Husband EM, Baker L, Jayaraj AP. Helicobacter pylori and peptic ulcer recurrence. Gut 1992;33:1293. [PMID: 1427385 DOI: 10.1136/gut.33.9.1293-b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Lam S. Treatment of Duodenal Ulcer with Sucralfate. Scandinavian Journal of Gastroenterology 2009;26:22-8. [DOI: 10.3109/00365529109093216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
8 Hunt RH. Treatment of peptic ulcer disease with sucralfate: a review. Am J Med 1991;91:102S-6S. [PMID: 1882894 DOI: 10.1016/0002-9343(91)90459-b] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Lam SK. Why Do Ulcers Heal with Sucralfate? Scandinavian Journal of Gastroenterology 2009;25:6-16. [DOI: 10.3109/00365529009091918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Winter TA, Louw JA, Marks IN, Jaskiewicz K, Lucre W, Callanan M. Effect of Sucralfate on Helicobacter pylori and Severity of Gastritis in Patients with Duodenal Ulcer. Scandinavian Journal of Gastroenterology 2009;30:85-8. [DOI: 10.3109/00365529509090279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
11 Marks I, Johnston DA, Young GO. Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate. The American Journal of Medicine 1991;91:S95-S101. [DOI: 10.1016/0002-9343(91)90458-a] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
12 Korman MG. Quality of healing in peptic ulcer disease—are H2 receptor antagonists all we need? Gastroenterol Jpn 1993;28:168-71. [DOI: 10.1007/bf02989229] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Kühl P, Baczako K, Stanescu A, Malfertheiner P. Loss of alkaline phosphatase activity in duodenal mucosa: a marker for precursors of gastric metaplasia? J Pathol 1990;162:317-22. [PMID: 2290116 DOI: 10.1002/path.1711620407] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
14 Ching C, Leake H, Misra S, Dwivedi M, Misra V, Tovey F, Baker L, Husband E, Mcphail G, Yiu Y, Jayaraj A. Therapy in Helicobacter pylori infection. The Lancet 1990;336:1380-1. [DOI: 10.1016/0140-6736(90)92934-a] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
15 Deane MN, Gregory M, Mars M. The creation of a measurable contusion injury in skeletal muscle. J S Afr Vet Assoc 2014;85:1031. [PMID: 25686259 DOI: 10.4102/jsava.v85i1.1031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Earnest DL. Maintenance Therapy in Peptic Ulcer Disease. Medical Clinics of North America 1991;75:1013-38. [DOI: 10.1016/s0025-7125(16)30427-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
17 Hadziselimovic F. Reply. Gut 1996;38:153-4. [DOI: 10.1136/gut.38.1.153-c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
18 Tovey FI. Acid and gastric metaplasia in the duodenum. Gut 1995;36:154. [PMID: 7890227 DOI: 10.1136/gut.36.1.154-a] [Reference Citation Analysis]
19 Tarnawski A, Santos AM, Hanke S, Stachura J, Douglass TG, Sarfeh IJ. Quality of gastric ulcer healing. Is it influenced by antiulcer drugs? Scand J Gastroenterol Suppl 1995;208:9-13. [PMID: 7777811 DOI: 10.3109/00365529509107755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Kim N, Lim SH, Lee KH, Choi SE. Long-Term Effect of Helicobacter pylori Eradication on Gastric Metaplasia in Patients With Duodenal Ulcer: . Journal of Clinical Gastroenterology 1998;27:246-52. [DOI: 10.1097/00004836-199810000-00013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
21 Bynum TE. Clinical aspects of gastroduodenal ulcer recurrence: an overview. Scand J Gastroenterol Suppl 1992;191:1-3. [PMID: 1357739 DOI: 10.3109/00365529209093221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
22 Korman MG. Influence of initial therapy on outcome of peptic ulcer. Scand J Gastroenterol Suppl 1995;208:21-3. [PMID: 7777799 DOI: 10.3109/00365529509107757] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
23 Tovey FI. Gastric metaplasia and Helicobacter pylori infection. Gut 1996;38:154. [PMID: 8566848 DOI: 10.1136/gut.38.1.154-a] [Reference Citation Analysis]
24 Saigenji K, Harasawa S, Iwasaki A, Asaka M, Asaki S, Fukutomi H, Kaneko E, Tsukamoto Y, Inoue M, Miwa T, Matsuo Y, Okabe H, Miyoshi A. Risk Factors For Duodenal Ulcer Recurrence: Three‐year Follow‐up during Famotidine Maintenance Therapy. Digestive Endoscopy 2007;7:226-33. [DOI: 10.1111/j.1443-1661.1995.tb00167.x] [Reference Citation Analysis]
25 Miyake K, Tsukui T, Shinji Y, Shinoki K, Hiratsuka T, Nishigaki H, Futagami S, Wada K, Gudis K, Iwakiri K. Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines. Helicobacter. 2004;9:130-137. [PMID: 15068414 DOI: 10.1111/j.1083-4389.2004.00209.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]